Clinical Trial Update: A Phase I Study of MLN6907 in Patients With Metastatic Colorectal [Phase 1]

View source ↗

Summary

A Phase I trial of MLN6907 in patients with metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MLN6907

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Imaging of Solid Gastrointestinal Tumors | Phase 1 | Status: COMPLETED